Skip to content

Clinical trials

Observational Liver Cirrhosis, Biliary trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Cirrhosis, Biliary Phase: Observational Country / region: United States Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20101
20111
20141
20152
20161
20171
20201
20222
20242
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting3
Active, not recruiting2
Terminated2
Enrolling by invitation1
Suspended1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ipsen3
Mayo Clinic3
Intercept Pharmaceuticals2
Al-Azhar University1
Northwestern University1
Sanford Health1
Stanford University1
Target PharmaSolutions, Inc.1
University of California, Davis1
University of Nebraska1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Cirrhosis, Biliary17
Cholangitis, Sclerosing3
Hepatitis, Autoimmune3
Addison Disease2
Arthritis, Rheumatoid2
Celiac Disease2
Cholangiocarcinoma2
Crohn Disease2
Fibrosis2
Multiple Sclerosis2

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.